Chacruna Institute is a registered California 501(c)(3) non-profit. We are a volunteer-led organization run by a team of experts and enthusiasts who give their time freely to bring education and cultural understanding about psychedelic plant medicines to a wider audience. We promote a bridge between the ceremonial use of sacred plants and psychedelic science and envisage a world where plant medicines and other psychedelics are preserved, protected, and valued as part of our cultural identity and integrated into our social, legal and health care systems. Help us to achieve our mission! Please consider becoming a monthly donor so that your impact spans the entire year. Support of any frequency or amount helps the cause.
To make a donation click the button below:
To register for monthly recurrent donations fill the form below:
On August 25, 2020, a proposal presented in Colombia’s Congress to regulate coca and its derivatives, including cocaine, made history. This article dispels the equation of coca and cocaine; highlights the sacredness of the plant to Indigenous Americas; analyzes the underlying questions of the legislative proposal; and discusses the new economic models and regulation of coca.
One of the psychoactive mushrooms described by Gordon Wasson in LIFE magazine (1957) is today an endangered species. This article describes how mycologists located the fungus Conocybe siligeneoides in the Sierra Mazateca of Oaxaca (Mexico).
Mexico is currently debating ritual and traditional uses, as well as non-Indigenous and therapeutic uses of entheogens. During the past year, two legal reform proposals have been introduced to Mexico’s drug policy reform landscape. One of which is focused on the reclassification of psilocybin mushrooms and peyote, and the second is a request for legal consumption of the same sacred plants. This article describes the initiatives’ intentions, analyzes the proposals’ impact on the landscape for drug reform, and highlights the importance of a multicultural and human rights perspective, especially for the protection of Indigenous peoples’ rights.
In February 2021, the Church of the Eagle and Condor (CEC) and the Chacruna Institute joined forces to initiate the “Ayahuasca Religious Freedom Initiative.” On March 16, 2021, lawyers for the CEC and Chacruna Institute filed Freedom of Information Act (“FOIA”) requests on U.S. Customs Border Patrol and the U.S. Drug Enforcement Agency. This article reviews the insights gained from the government’s disclosures, or lack thereof, to the Initiative’s public records requests.
For four years, Soul Quest and their lawyers petitioned for Religious Freedom Restoration Exemption against the DEA for interfering with ayahuasca ceremonies. On April 16, 2021, the DEA’s Diversion Control Division denied their petition to carry on its ayahuasca ceremonies legally. This article describes key takeaways on the DEA’s denial, the impacts for the larger ayahuasca community, and the road ahead.
“The Right to Try Act” gives patients with life-threatening diseases a way to access investigational drugs that are not yet approved by the FDA. The Advanced Integrative Medical Science Institute, a Seattle-based palliative care clinic, has partnered with a patient rights attorney to appeal the DEA to be able to provide psilocybin-assisted therapy for two of their patients with life-threatening diseases.
In recent times, there has been more advances in medical research on cannabis. Francisco Savoi de Arauja and Mauro Machado Chaiben demystify the modalities that go beyond the medical model. They primarily focus on the political need to decriminalize marijuana, and include references to the religious and social uses of marijuana by Rastafarian culture, Santo Daime religion, and “Cannabis Social Clubs.”
The Indigenous Peyote Conservation Communication Committee wrote a letter to the psychedelic community regarding the inclusion of Peyote in decriminalization measures. This letter provides context, history, and details about Native Americans’ relationship with Peyote, the Native American Church, and NAC’s conservation efforts, and also includes suggestions of how psychedelic and decriminalization movements can be an ally to Native American communities.
Marcelo Leite, Ph.D., summarizes how the medicalization and legalization regulatory models for psilocybin-assisted therapy can “naturally coexist within an integrated framework.” There are advantages and limitations to each model, and as investors begin to invest their attention on the emerging psychedelic therapies and research, it is important for all psychedelic organizations to work in tandem with each other’s framework as it will best serve the movement and public access for psilocybin-assisted therapy.